Thalidomide to be tested on patients as bone marrow cancer drug

Thalidomide to be tested on patients as bone marrow cancer drug

TOKYO, Japan - Two officials of Fujimoto Pharmaceutical Corp. speak at a press conference in Tokyoon July 20. They said the company will begin testing thalidomide on patients as a bone marrow cancer treatment as early as in August, more than 40 years after the agent, notorious for severe birth defects, was banned in Japan.

Thalidomide sufferer tells of agony

Thalidomide sufferer tells of agony

TOKYO, Japan - Yukari Masuyama, one of the thalidomide victims, was born in Hokkaido in 1963, with both arms missing.

Firm selling thalidomide ordered to recall

Firm selling thalidomide ordered to recall

KOBE, Japan - Photo taken Nov. 5 shows a factory run by Maruni Seiyu, an Osaka-based pharmaceutical firm, which was found to have sold thalidomide, a drug still used in some cancer treatment despite a 1962 ban, without authorization. The Hyogo prefectural government ordered the company to recall the product.

Firm selling thalidomide ordered to recall

Firm selling thalidomide ordered to recall

KOBE, Japan - Photo taken Nov. 5 shows a factory run by Maruni Seiyu, an Osaka-based pharmaceutical firm, which was found to have sold thalidomide, a drug still used in some cancer treatment despite a 1962 ban, without authorization. The Hyogo prefectural government ordered the company to recall the product. (Kyodo)

Children of the Cross: The Horrific New Drug Scourge

The Ministry of Health and Welfare lags behind in dealing with the problem of deformed children caused by thalidomide. 　 The Ministry of Health and Welfare has been slow to deal with the problem of deformed children caused by thalidomide. Interview with a doctor Interview with parents of a seal-like deformed child Meeting of people with deformed children Surgery for seal-like deformities Advances in medical technology, *Filming date unknown, Release date: March 15, 1963.

Thalidomide to be tested on patients as bone marrow cancer drug

Thalidomide to be tested on patients as bone marrow cancer drug

TOKYO, Japan - Two officials of Fujimoto Pharmaceutical Corp. speak at a press conference in Tokyoon July 20. They said the company will begin testing thalidomide on patients as a bone marrow cancer treatment as early as in August, more than 40 years after the agent, notorious for severe birth defects, was banned in Japan. (Kyodo)